Sun Pharma to announce fourth quarter results on May 26, 2023

Sun Pharma launches CEQUA, a novel therapy for Dry Eye Disease in India Source link

Osteoarthritis Candidate MM-II Showed Durable Pain Relief in Global Phase 2b Study Source link

Sun Pharma - Milmet Labs merger Source link

Late-Breaking Phase 3 Data at AAD 2023 Show Oral Investigational Medicine Deuruxolitinib Significantly Improved Scalp Hair Regrowth in Alopecia Areata...

Sun Pharma completes acquisition of Concert Pharmaceuticals Source link

Sun Pharma Announces US FDA Approval for Generic Lenalidomide Capsules Source link